H-CYTE Inc logo

H-CYTE Inc

$ 6.00 0 (0%) 11:08 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 1.77M
Enterprise V:
$ 7.80M
Volume:
-
Avg Vol (2M):
229.00
Volume:
-
Market Cap $:
1.77M
PE Ratio:
At Loss
Avg Vol (2-Month):
229.00
Enterprise Value $:
7.80M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -21.5
Debt-to-Equity -0.85
Debt-to-EBITDA -0.74
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -350.92
Distress
Grey
Safe
Beneish M-Score 3.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.76
9-Day RSI 49.11
14-Day RSI 49.48
6-1 Month Momentum % -81.2
12-1 Month Momentum % -88.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.04
Quick Ratio 0.04
Cash Ratio 0.01
Days Sales Outstanding 5.54
Days Payable 711.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -88
Name Current Vs Industry Vs History
Gross Margin % 67.07
Operating Margin % -281.28
Net Margin % -634.46
ROA % -970.01
ROIC % -85.25
ROC (Joel Greenblatt) % -7213.74

Financials

HCYT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:HCYT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.239
EPS (TTM) ($) -36.089
Beta 0.75
Volatility % 92.74
14-Day RSI 49.48
14-Day ATR ($) 0.201733
20-Day SMA ($) 5.964
12-1 Month Momentum % -88.98
52-Week Range ($) 2.02 - 77
Shares Outstanding (Mil) 0.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

H-CYTE Inc Filings

Document Form Filing Date
No Filing Data

H-CYTE Inc Analysis

Share your research

Headlines

See More
No news.